[New era of tumor immunotherapy].
Yoshitake
Yoshihiro
Y
Department of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University.
Nakatsura
Tetsuya
T
Nishimura
Yasuharu
Y
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000145:classification / Q000302:isolation & purification; D019496:Cancer Vaccines / Q000627:therapeutic use; D049109:Cell Proliferation; D003602:Cytotoxicity, Immunologic; D006706:Homeostasis / Q000276:immunology; D006801:Humans; D007157:Immunologic Surveillance / Q000276:immunology; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D007694:Killer Cells, Natural / Q000276:immunology; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D022223:Vaccines, Subunit / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D022223:Vaccines, Subunit